Works by Vollmer, Timothy L

Results: 27

Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.

Published in:

Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.689975

By:

Kammeyer, Ryan;
Mizenko, Christopher;
Sillau, Stefan;
Richie, Alanna;
Owens, Gregory;
Nair, Kavita V.;
Alvarez, Enrique;
Vollmer, Timothy L.;
Bennett, Jeffrey L.;
Piquet, Amanda L.

Publication type:

Article

A Longitudinal, Observational Analysis of Neuronal Injury Biomarkers in a Case Report of a Patient With Paraneoplastic Anti-CRMP5 Antibody-Associated Transverse Myelitis.

Published in:

Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.691509

By:

Mizenko, Christopher;
Bennett, Jeffrey L.;
Owens, Gregory;
Vollmer, Timothy L.;
Piquet, Amanda L.

Publication type:

Article

CLINICALLY ISOLATED SYNDROME: EVALUATION, RISK STRATIFICATION, AND TREATMENT DECISIONS.

Published in:

Johns Hopkins Advanced Studies in Medicine, 2008, v. 8, n. 8, p. 257

By:

Cree, Bruce;
Vollmer, Timothy L.

Publication type:

Article

Therapeutic Decisions in Multiple Sclerosis Moving Beyond Efficacy.

Published in:

JAMA Neurology, 2013, v. 70, n. 10, p. 1315, doi. 10.1001/jamaneurol.2013.3510

By:

Brück, Wolfgang;
Gold, Ralf;
Lund, Brett T.;
Oreja-Guevara, Celia;
Prat, Alexandre;
Spencer, Collin M.;
Steinman, Lawrence;
Tintoré, Mar;
Vollmer, Timothy L.;
Weber, Martin S.;
Weiner, Leslie P.;
Ziemssen, Tjalf;
Zamvil, Scott S.

Publication type:

Article

Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis.

Published in:

Clinical Medicine Insights: Therapeutics, 2011, n. 3, p. 151, doi. 10.4137/CMT.S2057

By:

Miravalle, Augusto;
Hendin, Barry;
Vollmer, Timothy L.;
Kala, Mrinalini

Publication type:

Article

Poster 230: Hand Function, Mobility, and Employment Status in the NARCOMS Registry.

Published in:

2010

By:

Tyry, Tuula;
Cutter, Gary R.;
Marrie, Ruth Ann;
Moreau, Rachel;
Salter, Amber;
Vollmer, Timothy L.

Publication type:

Abstract

Poster 230: Hand Function, Mobility, and Employment Status in the NARCOMS Registry

Published in:

2010

By:

Tyry, Tuula;
Cutter, Gary R.;
Marrie, Ruth Ann;
Moreau, Rachel;
Salter, Amber;
Vollmer, Timothy L.

Publication type:

Abstract

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosisAppendix of investigators on p. 787.

Published in:

Annals of Neurology, 2006, v. 59, n. 5, p. 780, doi. 10.1002/ana.20828

By:

Hillel S. Panitch;
Ronald A. Thisted;
Richard A. Smith;
Daniel R. Wynn;
James P. Wymer;
Anat Achiron;
Timothy L. Vollmer;
Raul N. Mandler;
Dennis W. Dietrich;
Malcolm Fletcher;
Laura E. Pope;
James E. Berg;
Ariel Miller

Publication type:

Article

Laquinimod Safety Profile.

Published in:

International Journal of MS Care, 2017, v. 19, n. 1, p. 16, doi. 10.7224/1537-2073.2015-024

By:

Sørensen, Per Soelberg;
Comi, Giancarlo;
Vollmer, Timothy L.;
Montalban, Xavier;
Kappos, Ludwig;
Dadon, Yuval;
Gorfine, Tali;
Margalit, Maya;
Sasson, Nissim;
Rubinchick, Svetlana;
Knappertz, Volker

Publication type:

Article

Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Evaluating Factors Associated with Infusion Related Reactions.

Published in:

Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211069359

By:

Alvarez, Enrique;
Nair, Kavita V.;
Sillau, Stefan;
Shelton, Ian;
Seale, Rebecca;
Selva, Sean;
Corboy, John;
Vollmer, Timothy L

Publication type:

Article

Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes.

Published in:

Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217319827618

By:

Kletenik, Isaiah;
Alvarez, Enrique;
Honce, Justin M.;
Valdez, Brooke;
Vollmer, Timothy L.;
Medina, Luis D.

Publication type:

Article

Multiple Sclerosis: New Approaches to Immunotherapy.

Published in:

Neuroscientist, 1996, v. 2, n. 2, p. 127, doi. 10.1177/107385849600200214

By:

Vollmer, Timothy L.

Publication type:

Article

CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2022, v. 28, n. 4, p. 608, doi. 10.1177/13524585211032803

By:

Comi, Giancarlo;
Dadon, Yuval;
Sasson, Nissim;
Steinerman, Joshua R;
Knappertz, Volker;
Vollmer, Timothy L;
Boyko, Alexey;
Vermersch, Patrick;
Ziemssen, Tjalf;
Montalban, Xavier;
Lublin, Fred D;
Rocca, Maria A;
Volkinshtein, Rita;
Rubinchick, Svetlana;
Halevy, Nitsan;
Filippi, Massimo

Publication type:

Article

A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing-remitting or secondary progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2011, v. 17, n. 2, p. 181, doi. 10.1177/1352458510384496

By:

Vollmer, Timothy L.;
Wynn, Daniel R.;
Shamsul Alam, M.;
Valdes, Joaquin

Publication type:

Article

Cell Cycle Activation in Postmitotic Neurons is Essential for DNA Repair.

Published in:

Cell Cycle, 2007, v. 6, n. 3, p. 318, doi. 10.4161/cc.6.3.3752

By:

Schwartz, Elena I.;
Smilenov, Lubomir B.;
Price, Mary A.;
Osredkar, Tracy;
Baker, Ronald A.;
Ghosh, Soma;
Fu-Dong Shi;
Vollmer, Timothy L.;
Lencinas, Alejandro;
Stearns, Diane M.;
Gorospe, Myriam;
Kruman, Inna I.

Publication type:

Article

Incorporating real-world clinical practice in multiple sclerosis economic evaluations.

Published in:

2015

By:

Brett McQueen, R;
Nair, Kavita V;
Vollmer, Timothy L;
Campbell, Jonathan D;
McQueen, R Brett

Publication type:

Editorial

Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?

Published in:

International Immunology, 2006, v. 18, n. 4, p. 537, doi. 10.1093/intimm/dxh394

By:

Youngheun Jee;
Ruolan Liu;
Xue-Feng Bai;
Denise I. Campagnolo;
Fu-Dong Shi;
Timothy L. Vollmer

Publication type:

Article

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.

Published in:

2021

By:

Piquet, Amanda L.;
Corboy, John R.;
Vollmer, Timothy L.

Publication type:

Letter

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2023, v. 10, n. 4, p. 579, doi. 10.1002/acn3.51745

By:

Barrera, Britney;
Simpson, Haley;
Engebretson, Eric;
Sillau, Stefan;
Valdez, Brooke;
Parra‐González, José;
Winger, Ryan C.;
Epperson, Lou Anne;
Banks, Ashley;
Pierce, Kathryn;
Spotts, Melanie;
O'Gean, Katie;
Alvarez, Enrique;
Gross, Robert;
Piquet, Amanda L.;
Schreiner, Teri;
Corboy, John R.;
Pei, Jinglan;
Vollmer, Timothy L.;
Nair, Kavita V.

Publication type:

Article

Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry.

Published in:

Multiple Sclerosis (13524585), 2005, v. 11, n. 1, p. 33, doi. 10.1191/1352458505ms1136oa

By:

Lo, Albert C.;
Hadjimichael, Olympia;
Vollmer, Timothy L.

Publication type:

Article

Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate.

Published in:

Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.01045

By:

Honce, Justin M.;
Nair, Kavita V.;
Hoyt, Brian D.;
Seale, Rebecca A.;
Sillau, Stefan;
Engebretson, Eric;
Schurr, Brittany;
Corboy, John R.;
Vollmer, Timothy L.;
Alvarez, Enrique

Publication type:

Article

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.

Published in:

2021

By:

Piquet, Amanda L.;
Corboy, John R.;
Vollmer, Timothy L.

Publication type:

Letter

A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.

Published in:

Pain Practice, 2014, v. 14, n. 8, p. 732, doi. 10.1111/papr.12127

By:

Vollmer, Timothy L.;
Robinson, Michael J.;
Risser, Richard C.;
Malcolm, Sandra K.

Publication type:

Article

Glatiramer acetate ameliorates experimental autoimmune neuritis.

Published in:

Immunology & Cell Biology, 2014, v. 92, n. 2, p. 164, doi. 10.1038/icb.2013.81

By:

Zhang, Cun‐Jin;
Zhai, Hui;
Yan, Yaping;
Hao, Junwei;
Li, Min‐Shu;
Jin, Wei‐Na;
Su, Ning;
Vollmer, Timothy L;
Shi, Fu‐Dong

Publication type:

Article

Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis.

Published in:

2018

By:

Kuerten, Stefanie;
Jackson, Leila J.;
Kaye, Joel;
Vollmer, Timothy L.

Publication type:

journal article

CCL2 recruitment of IL-6-producing CD11b.

Published in:

European Journal of Immunology, 2008, v. 38, n. 7, p. 1877, doi. 10.1002/eji.200737973

By:

Bai, Ying;
Liu, Ruolan;
Huang, DeRen;
La Cava, Antonio;
Tang, Yi-yuan;
Iwakura, Yoichiro;
Campagnolo, Denise I.;
Vollmer, Timothy L.;
Ransohoff, Richard M.;
Shi, Fu-Dong

Publication type:

Article

Neuromuscular responses of patients with multiple sclerosis.

Published in:

Muscle & Nerve, 1992, v. 15, n. 10, p. 1123, doi. 10.1002/mus.880151011

By:

Rice, Charles L.;
Vollmer, Timothy L.;
Bigland-Ritchie, Brenda

Publication type:

Article